Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Neoplasms | 47 | 2024 | 2561 | 4.390 |
Why?
|
Soft Tissue Neoplasms | 39 | 2024 | 1163 | 4.200 |
Why?
|
Chordoma | 26 | 2023 | 349 | 3.760 |
Why?
|
Sarcoma | 40 | 2023 | 1802 | 3.710 |
Why?
|
Chondrosarcoma | 10 | 2024 | 305 | 2.320 |
Why?
|
RNA-Binding Protein EWS | 14 | 2024 | 211 | 2.050 |
Why?
|
Osteosarcoma | 16 | 2024 | 908 | 2.040 |
Why?
|
Liposarcoma | 7 | 2020 | 288 | 1.940 |
Why?
|
Giant Cell Tumor of Bone | 8 | 2022 | 119 | 1.710 |
Why?
|
Bone Cysts, Aneurysmal | 3 | 2022 | 70 | 1.670 |
Why?
|
Chondroblastoma | 6 | 2020 | 47 | 1.560 |
Why?
|
Rhabdomyosarcoma | 5 | 2022 | 358 | 1.500 |
Why?
|
Fibrosarcoma | 5 | 2023 | 313 | 1.460 |
Why?
|
Myoepithelioma | 4 | 2019 | 26 | 1.300 |
Why?
|
Lipoma | 6 | 2020 | 294 | 1.230 |
Why?
|
Gene Fusion | 7 | 2022 | 356 | 1.230 |
Why?
|
Vulvar Neoplasms | 9 | 2022 | 266 | 1.210 |
Why?
|
Chondroma | 4 | 2020 | 53 | 1.120 |
Why?
|
Osteoblastoma | 2 | 2022 | 24 | 1.070 |
Why?
|
Joint Diseases | 3 | 2021 | 461 | 0.980 |
Why?
|
Uterine Neoplasms | 7 | 2023 | 1424 | 0.980 |
Why?
|
Immunohistochemistry | 49 | 2024 | 11061 | 0.970 |
Why?
|
Spinal Neoplasms | 11 | 2018 | 714 | 0.880 |
Why?
|
Cell Dedifferentiation | 3 | 2020 | 125 | 0.870 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 3 | 2020 | 361 | 0.850 |
Why?
|
Pelvic Neoplasms | 2 | 2022 | 249 | 0.800 |
Why?
|
NFATC Transcription Factors | 2 | 2021 | 392 | 0.770 |
Why?
|
Bone Cysts | 1 | 2021 | 48 | 0.730 |
Why?
|
Knee Joint | 4 | 2018 | 1682 | 0.710 |
Why?
|
Sarcoma, Clear Cell | 3 | 2022 | 73 | 0.700 |
Why?
|
Epithelioid Cells | 5 | 2020 | 61 | 0.690 |
Why?
|
Hemangiosarcoma | 7 | 2023 | 214 | 0.680 |
Why?
|
In Situ Hybridization | 3 | 2020 | 1892 | 0.670 |
Why?
|
Gene Rearrangement | 8 | 2021 | 1142 | 0.660 |
Why?
|
Neurofibrosarcoma | 1 | 2019 | 28 | 0.660 |
Why?
|
Leiomyosarcoma | 4 | 2022 | 426 | 0.640 |
Why?
|
Humerus | 2 | 2021 | 273 | 0.640 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2024 | 456 | 0.640 |
Why?
|
Sarcoma, Synovial | 6 | 2023 | 157 | 0.630 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 361 | 0.630 |
Why?
|
In Situ Hybridization, Fluorescence | 15 | 2024 | 2510 | 0.630 |
Why?
|
Fibula | 1 | 2021 | 270 | 0.620 |
Why?
|
Myxoma | 3 | 2013 | 114 | 0.610 |
Why?
|
Mucin-4 | 2 | 2014 | 33 | 0.600 |
Why?
|
Synovial Cyst | 1 | 2018 | 34 | 0.590 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 6 | 2014 | 705 | 0.560 |
Why?
|
Diagnosis, Differential | 30 | 2024 | 12985 | 0.550 |
Why?
|
Carcinoma | 3 | 2021 | 2324 | 0.520 |
Why?
|
Middle Aged | 118 | 2024 | 223257 | 0.520 |
Why?
|
Neoplasms, Radiation-Induced | 4 | 2019 | 543 | 0.520 |
Why?
|
Spine | 3 | 2018 | 1134 | 0.510 |
Why?
|
Female | 148 | 2024 | 396520 | 0.500 |
Why?
|
Cell Differentiation | 12 | 2023 | 11651 | 0.490 |
Why?
|
Adult | 121 | 2024 | 223307 | 0.480 |
Why?
|
Humans | 216 | 2024 | 766766 | 0.480 |
Why?
|
S100 Proteins | 8 | 2022 | 215 | 0.470 |
Why?
|
Femur | 2 | 2021 | 1318 | 0.470 |
Why?
|
Fibroma | 4 | 2018 | 196 | 0.470 |
Why?
|
Oncogene Proteins, Fusion | 9 | 2024 | 1609 | 0.470 |
Why?
|
Calmodulin-Binding Proteins | 6 | 2019 | 238 | 0.460 |
Why?
|
Sacrum | 4 | 2018 | 273 | 0.460 |
Why?
|
Male | 139 | 2024 | 364142 | 0.450 |
Why?
|
Neoplasm Recurrence, Local | 18 | 2023 | 9404 | 0.450 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1255 | 0.450 |
Why?
|
Extremities | 9 | 2014 | 869 | 0.450 |
Why?
|
Nerve Sheath Neoplasms | 6 | 2021 | 169 | 0.440 |
Why?
|
Hemangioma | 3 | 2023 | 727 | 0.440 |
Why?
|
Synovial Membrane | 3 | 2018 | 536 | 0.430 |
Why?
|
Skull Base Neoplasms | 4 | 2024 | 280 | 0.430 |
Why?
|
Meningioma | 2 | 2022 | 1221 | 0.430 |
Why?
|
Aged | 89 | 2023 | 171343 | 0.430 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2015 | 723 | 0.420 |
Why?
|
Bone Diseases | 2 | 2021 | 412 | 0.410 |
Why?
|
Young Adult | 49 | 2024 | 59939 | 0.400 |
Why?
|
Mutation | 15 | 2023 | 30213 | 0.390 |
Why?
|
Tongue Neoplasms | 1 | 2013 | 185 | 0.380 |
Why?
|
Keratins | 5 | 2010 | 499 | 0.380 |
Why?
|
Oncogene Fusion | 3 | 2020 | 84 | 0.380 |
Why?
|
Hashimoto Disease | 1 | 2012 | 108 | 0.360 |
Why?
|
Sciatic Nerve | 1 | 2014 | 627 | 0.360 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2007 | 243 | 0.350 |
Why?
|
Giant Cell Tumors | 4 | 2015 | 89 | 0.350 |
Why?
|
Histiocytosis, Sinus | 1 | 2010 | 45 | 0.350 |
Why?
|
Polyethylenes | 3 | 2018 | 294 | 0.350 |
Why?
|
Genital Neoplasms, Female | 3 | 2022 | 534 | 0.350 |
Why?
|
Neurilemmoma | 4 | 2021 | 522 | 0.350 |
Why?
|
RNA-Binding Protein FUS | 3 | 2020 | 77 | 0.340 |
Why?
|
Adolescent | 53 | 2024 | 88904 | 0.340 |
Why?
|
Transcription Factors | 8 | 2021 | 12150 | 0.330 |
Why?
|
Plasma Cells | 2 | 2012 | 599 | 0.330 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3666 | 0.310 |
Why?
|
Adenoma, Oxyphilic | 1 | 2010 | 151 | 0.310 |
Why?
|
Osteoma, Osteoid | 2 | 2007 | 94 | 0.310 |
Why?
|
Ovarian Neoplasms | 6 | 2019 | 4904 | 0.300 |
Why?
|
Sarcoma, Small Cell | 2 | 2022 | 17 | 0.300 |
Why?
|
Thyroid Gland | 2 | 2012 | 1170 | 0.300 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2010 | 117 | 0.300 |
Why?
|
Neurofibromatosis 1 | 4 | 2019 | 561 | 0.300 |
Why?
|
Prognosis | 22 | 2024 | 29948 | 0.300 |
Why?
|
Skull | 2 | 2014 | 819 | 0.290 |
Why?
|
Aged, 80 and over | 36 | 2021 | 59550 | 0.290 |
Why?
|
Comparative Genomic Hybridization | 4 | 2019 | 474 | 0.290 |
Why?
|
Mandibular Neoplasms | 2 | 2010 | 131 | 0.290 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 2 | 2018 | 78 | 0.280 |
Why?
|
Actins | 7 | 2020 | 2060 | 0.280 |
Why?
|
Angiomyoma | 2 | 1997 | 11 | 0.280 |
Why?
|
Disease-Free Survival | 8 | 2023 | 6850 | 0.270 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2013 | 950 | 0.270 |
Why?
|
Nose Neoplasms | 1 | 2009 | 250 | 0.270 |
Why?
|
Desmin | 4 | 2020 | 99 | 0.260 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 3 | 2014 | 104 | 0.260 |
Why?
|
DNA-Binding Proteins | 6 | 2022 | 9611 | 0.260 |
Why?
|
Solitary Fibrous Tumors | 2 | 2022 | 70 | 0.250 |
Why?
|
Translocation, Genetic | 5 | 2019 | 1392 | 0.250 |
Why?
|
Immunoglobulin G | 3 | 2012 | 4559 | 0.250 |
Why?
|
Collagen | 5 | 2010 | 2635 | 0.250 |
Why?
|
Pathology, Clinical | 2 | 2022 | 374 | 0.250 |
Why?
|
Rhabdomyosarcoma, Embryonal | 2 | 2018 | 99 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2024 | 8621 | 0.240 |
Why?
|
Notochord | 3 | 2023 | 37 | 0.240 |
Why?
|
Sarcoma, Alveolar Soft Part | 2 | 2014 | 44 | 0.240 |
Why?
|
beta Catenin | 4 | 2024 | 1048 | 0.240 |
Why?
|
Retroperitoneal Neoplasms | 5 | 2010 | 335 | 0.240 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2005 | 43 | 0.240 |
Why?
|
Biopsy | 12 | 2022 | 6779 | 0.240 |
Why?
|
Liposarcoma, Myxoid | 3 | 2014 | 60 | 0.230 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2016 | 2839 | 0.230 |
Why?
|
Gene Deletion | 4 | 2019 | 2669 | 0.230 |
Why?
|
Thyroid Neoplasms | 2 | 2015 | 2355 | 0.230 |
Why?
|
Adenocarcinoma | 5 | 2019 | 6359 | 0.230 |
Why?
|
RNA-Binding Proteins | 4 | 2014 | 1884 | 0.230 |
Why?
|
Mandibular Condyle | 1 | 2024 | 118 | 0.220 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2056 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.220 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2017 | 594 | 0.220 |
Why?
|
Thoracic Vertebrae | 3 | 2018 | 613 | 0.220 |
Why?
|
Carcinoma, Papillary | 3 | 2015 | 791 | 0.210 |
Why?
|
Myositis Ossificans | 1 | 2024 | 77 | 0.210 |
Why?
|
Proto-Oncogene Proteins | 5 | 2021 | 4522 | 0.210 |
Why?
|
Hemangiopericytoma | 3 | 2008 | 71 | 0.210 |
Why?
|
Bone and Bones | 3 | 2022 | 2559 | 0.210 |
Why?
|
Cell Nucleus | 6 | 2016 | 2870 | 0.210 |
Why?
|
Peripheral Nervous System Neoplasms | 2 | 2017 | 133 | 0.210 |
Why?
|
Fibromatosis, Aggressive | 1 | 2024 | 125 | 0.210 |
Why?
|
Leiomyoma | 3 | 2023 | 644 | 0.200 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2010 | 684 | 0.200 |
Why?
|
Cyclin D1 | 1 | 2024 | 454 | 0.200 |
Why?
|
Neoadjuvant Therapy | 5 | 2022 | 2902 | 0.200 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2019 | 310 | 0.200 |
Why?
|
Child, Preschool | 16 | 2024 | 42577 | 0.200 |
Why?
|
Histiocytoma, Malignant Fibrous | 2 | 2014 | 54 | 0.200 |
Why?
|
Chromosome Deletion | 2 | 2019 | 1384 | 0.200 |
Why?
|
Receptors, Steroid | 1 | 2022 | 157 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 17 | 2024 | 36567 | 0.200 |
Why?
|
Hemangioendothelioma | 2 | 2016 | 112 | 0.200 |
Why?
|
Peritoneal Neoplasms | 3 | 2022 | 706 | 0.200 |
Why?
|
Osteolysis, Essential | 2 | 2015 | 30 | 0.200 |
Why?
|
Bone Density Conservation Agents | 2 | 2021 | 791 | 0.200 |
Why?
|
Vitamin E | 2 | 2018 | 872 | 0.190 |
Why?
|
Child | 34 | 2024 | 80668 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2023 | 2948 | 0.190 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2929 | 0.190 |
Why?
|
Pathology, Surgical | 2 | 2014 | 147 | 0.190 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2024 | 226 | 0.190 |
Why?
|
Vimentin | 4 | 2013 | 257 | 0.190 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.180 |
Why?
|
Monitoring, Immunologic | 1 | 2021 | 99 | 0.180 |
Why?
|
Kidney Neoplasms | 4 | 2015 | 4282 | 0.180 |
Why?
|
Genes, Neoplasm | 2 | 2014 | 369 | 0.180 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2000 | 68 | 0.180 |
Why?
|
Hyaline Cartilage | 1 | 2020 | 10 | 0.180 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2020 | 260 | 0.180 |
Why?
|
Bone Resorption | 1 | 2024 | 721 | 0.180 |
Why?
|
Zebrafish | 4 | 2018 | 3035 | 0.180 |
Why?
|
Melanoma | 2 | 2022 | 5700 | 0.180 |
Why?
|
Microscopy, Electron | 7 | 2003 | 2551 | 0.170 |
Why?
|
Histones | 3 | 2020 | 2593 | 0.170 |
Why?
|
Treatment Outcome | 24 | 2023 | 65273 | 0.170 |
Why?
|
DNA Mutational Analysis | 5 | 2018 | 4114 | 0.170 |
Why?
|
Angiofibroma | 2 | 2001 | 55 | 0.170 |
Why?
|
Homeodomain Proteins | 3 | 2021 | 2430 | 0.170 |
Why?
|
Vaginal Neoplasms | 2 | 2001 | 105 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 20708 | 0.170 |
Why?
|
Predictive Value of Tests | 8 | 2019 | 15416 | 0.170 |
Why?
|
Protein Isoforms | 1 | 2024 | 1716 | 0.160 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2021 | 156 | 0.160 |
Why?
|
Mesothelioma | 2 | 2022 | 774 | 0.160 |
Why?
|
Muscle Cells | 1 | 2020 | 194 | 0.160 |
Why?
|
Neurofibroma | 1 | 1999 | 95 | 0.160 |
Why?
|
Florida | 1 | 2020 | 417 | 0.160 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 4970 | 0.160 |
Why?
|
Adenoma | 3 | 2022 | 2155 | 0.160 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2020 | 698 | 0.160 |
Why?
|
Myofibroblasts | 1 | 2020 | 230 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
PTEN Phosphohydrolase | 3 | 2014 | 1117 | 0.150 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2019 | 432 | 0.150 |
Why?
|
Pyridines | 2 | 2024 | 2888 | 0.150 |
Why?
|
Genes, Retinoblastoma | 1 | 1998 | 125 | 0.150 |
Why?
|
Materials Testing | 2 | 2018 | 870 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 209 | 0.150 |
Why?
|
Hemangioendothelioma, Epithelioid | 2 | 2013 | 52 | 0.150 |
Why?
|
Peroxides | 1 | 2018 | 76 | 0.150 |
Why?
|
Mesoderm | 1 | 2001 | 679 | 0.150 |
Why?
|
Photons | 2 | 2014 | 588 | 0.150 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 501 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 230 | 0.150 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2003 | 957 | 0.140 |
Why?
|
Hyperplasia | 1 | 2021 | 1150 | 0.140 |
Why?
|
Retrospective Studies | 30 | 2024 | 81635 | 0.140 |
Why?
|
Immunoenzyme Techniques | 6 | 2001 | 1697 | 0.140 |
Why?
|
RANK Ligand | 1 | 2019 | 321 | 0.140 |
Why?
|
Muscle Neoplasms | 1 | 1998 | 130 | 0.140 |
Why?
|
Muscular Diseases | 1 | 2002 | 551 | 0.140 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 309 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1105 | 0.140 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 273 | 0.140 |
Why?
|
Myofibroma | 1 | 2017 | 45 | 0.140 |
Why?
|
Neoplasm Proteins | 6 | 2021 | 3601 | 0.140 |
Why?
|
Hematologic Diseases | 1 | 2021 | 502 | 0.140 |
Why?
|
Necrosis | 3 | 2024 | 1616 | 0.140 |
Why?
|
Fibroma, Desmoplastic | 1 | 1996 | 6 | 0.140 |
Why?
|
Lumbar Vertebrae | 3 | 2015 | 1878 | 0.140 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2018 | 234 | 0.140 |
Why?
|
Radiotherapy Dosage | 8 | 2024 | 2911 | 0.140 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2016 | 53 | 0.140 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 199 | 0.130 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2017 | 62 | 0.130 |
Why?
|
Sclerosis | 2 | 2014 | 211 | 0.130 |
Why?
|
T-Box Domain Proteins | 2 | 2023 | 471 | 0.130 |
Why?
|
Nuclear Proteins | 2 | 2021 | 5795 | 0.130 |
Why?
|
Survival Rate | 10 | 2024 | 12825 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 505 | 0.130 |
Why?
|
Smooth Muscle Tumor | 1 | 1996 | 65 | 0.130 |
Why?
|
HLA Antigens | 1 | 2021 | 1339 | 0.130 |
Why?
|
Lipomatosis | 1 | 2016 | 112 | 0.130 |
Why?
|
Stapes | 1 | 2015 | 89 | 0.130 |
Why?
|
Osteomyelitis | 2 | 2016 | 408 | 0.130 |
Why?
|
Gene Amplification | 1 | 2020 | 1088 | 0.120 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2015 | 142 | 0.120 |
Why?
|
Neoplasm, Residual | 4 | 2014 | 1012 | 0.120 |
Why?
|
Osteoblasts | 1 | 2021 | 1144 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2039 | 0.120 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 306 | 0.120 |
Why?
|
Mandibular Diseases | 1 | 2016 | 117 | 0.120 |
Why?
|
Intestines | 2 | 2016 | 1904 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4570 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 258 | 0.120 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2019 | 572 | 0.120 |
Why?
|
Repressor Proteins | 4 | 2022 | 2978 | 0.120 |
Why?
|
MicroRNAs | 3 | 2019 | 3792 | 0.120 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2015 | 101 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 7 | 2015 | 1787 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1362 | 0.120 |
Why?
|
Biopsy, Fine-Needle | 3 | 2018 | 1131 | 0.120 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2014 | 48 | 0.120 |
Why?
|
Fibrous Dysplasia, Monostotic | 1 | 2014 | 8 | 0.120 |
Why?
|
Thigh | 1 | 1995 | 236 | 0.120 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5789 | 0.110 |
Why?
|
Telepathology | 1 | 2014 | 77 | 0.110 |
Why?
|
Cell Line, Tumor | 11 | 2024 | 17088 | 0.110 |
Why?
|
Activating Transcription Factor 1 | 1 | 2013 | 26 | 0.110 |
Why?
|
Knee | 1 | 1995 | 274 | 0.110 |
Why?
|
Zebrafish Proteins | 2 | 2018 | 1018 | 0.110 |
Why?
|
Amyloidosis | 1 | 2021 | 877 | 0.110 |
Why?
|
Cecal Neoplasms | 1 | 1993 | 27 | 0.110 |
Why?
|
Telomerase | 1 | 2019 | 750 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 3 | 2010 | 2057 | 0.110 |
Why?
|
Fibrosis | 4 | 2018 | 2077 | 0.110 |
Why?
|
Follow-Up Studies | 16 | 2024 | 39309 | 0.110 |
Why?
|
Ossification, Heterotopic | 2 | 2009 | 240 | 0.110 |
Why?
|
Vulvar Diseases | 2 | 2008 | 64 | 0.110 |
Why?
|
Shoulder | 1 | 1995 | 300 | 0.110 |
Why?
|
Neoplasm Invasiveness | 4 | 2018 | 3609 | 0.110 |
Why?
|
Fetal Proteins | 1 | 2013 | 100 | 0.110 |
Why?
|
Limb Salvage | 1 | 2016 | 488 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 1351 | 0.110 |
Why?
|
RNA | 2 | 2020 | 2715 | 0.110 |
Why?
|
Mast-Cell Sarcoma | 1 | 2012 | 46 | 0.110 |
Why?
|
Debridement | 1 | 2016 | 494 | 0.110 |
Why?
|
Membrane Proteins | 4 | 2018 | 7868 | 0.110 |
Why?
|
Radiotherapy, Conformal | 2 | 2014 | 545 | 0.100 |
Why?
|
Histiocytes | 2 | 2010 | 97 | 0.100 |
Why?
|
Stem Cell Niche | 2 | 2016 | 346 | 0.100 |
Why?
|
Myxosarcoma | 1 | 2012 | 11 | 0.100 |
Why?
|
Radiography | 5 | 2010 | 6968 | 0.100 |
Why?
|
Furans | 1 | 2014 | 199 | 0.100 |
Why?
|
Stem Cells | 3 | 2016 | 3537 | 0.100 |
Why?
|
Combined Modality Therapy | 9 | 2016 | 8540 | 0.100 |
Why?
|
Fibronectins | 1 | 2016 | 722 | 0.100 |
Why?
|
Appendix | 1 | 1993 | 110 | 0.100 |
Why?
|
Intermediate Filaments | 2 | 2010 | 171 | 0.100 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2013 | 348 | 0.100 |
Why?
|
Arthroplasty, Replacement | 2 | 2018 | 311 | 0.100 |
Why?
|
Osteolysis | 1 | 2014 | 273 | 0.100 |
Why?
|
Mesentery | 2 | 2022 | 201 | 0.100 |
Why?
|
Antineoplastic Agents | 7 | 2019 | 13643 | 0.100 |
Why?
|
Remote Consultation | 1 | 2014 | 241 | 0.100 |
Why?
|
Terminology as Topic | 2 | 1996 | 1540 | 0.100 |
Why?
|
Paneth Cells | 1 | 2012 | 99 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 3 | 2015 | 3186 | 0.100 |
Why?
|
Chondrosarcoma, Mesenchymal | 1 | 2011 | 12 | 0.090 |
Why?
|
Jaw Neoplasms | 1 | 2012 | 71 | 0.090 |
Why?
|
Molecular Biology | 1 | 2015 | 573 | 0.090 |
Why?
|
Muscle Development | 1 | 2013 | 258 | 0.090 |
Why?
|
Joint Loose Bodies | 1 | 2011 | 19 | 0.090 |
Why?
|
Thyroid Function Tests | 1 | 2012 | 289 | 0.090 |
Why?
|
Hemosiderin | 1 | 2011 | 41 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1725 | 0.090 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 2011 | 32 | 0.090 |
Why?
|
Temporal Bone | 1 | 2015 | 683 | 0.090 |
Why?
|
Pelvis | 1 | 2015 | 737 | 0.090 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2011 | 138 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2013 | 614 | 0.090 |
Why?
|
Oncogenes | 2 | 2014 | 1231 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2926 | 0.090 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 1993 | 523 | 0.090 |
Why?
|
Antioxidants | 1 | 2018 | 1671 | 0.090 |
Why?
|
Maxillary Neoplasms | 1 | 2010 | 47 | 0.090 |
Why?
|
Ankle | 1 | 2013 | 353 | 0.090 |
Why?
|
Cytoplasmic Vesicles | 1 | 2010 | 72 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2045 | 0.090 |
Why?
|
Gene Dosage | 2 | 2013 | 1211 | 0.090 |
Why?
|
Fatal Outcome | 4 | 2006 | 1838 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3738 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2014 | 562 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2885 | 0.090 |
Why?
|
Cytoplasmic Structures | 1 | 2010 | 21 | 0.090 |
Why?
|
Desmosomes | 1 | 2010 | 73 | 0.090 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 630 | 0.090 |
Why?
|
Thyroiditis | 1 | 2010 | 86 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2014 | 18330 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1039 | 0.080 |
Why?
|
Crystallization | 1 | 2011 | 518 | 0.080 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2011 | 304 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 6 | 2018 | 6512 | 0.080 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2010 | 220 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2105 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1899 | 0.080 |
Why?
|
Tumor Burden | 4 | 2020 | 1900 | 0.080 |
Why?
|
Synovitis | 1 | 2011 | 217 | 0.080 |
Why?
|
Appendiceal Neoplasms | 1 | 1991 | 155 | 0.080 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 324 | 0.080 |
Why?
|
Phenotype | 4 | 2020 | 16724 | 0.080 |
Why?
|
Histone Acetyltransferases | 1 | 2011 | 332 | 0.080 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 1999 | 325 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 723 | 0.080 |
Why?
|
Signal Transduction | 5 | 2018 | 23619 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 1885 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2014 | 561 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1762 | 0.080 |
Why?
|
Genotype | 2 | 2013 | 13036 | 0.080 |
Why?
|
Immune Tolerance | 3 | 2003 | 2325 | 0.080 |
Why?
|
Adipocytes | 1 | 1995 | 1196 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 9525 | 0.080 |
Why?
|
SOX9 Transcription Factor | 1 | 2009 | 145 | 0.080 |
Why?
|
Paranasal Sinuses | 1 | 2011 | 267 | 0.080 |
Why?
|
Stromal Cells | 3 | 2012 | 1334 | 0.080 |
Why?
|
Organelles | 2 | 2001 | 265 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1741 | 0.070 |
Why?
|
Proteoglycans | 1 | 2011 | 806 | 0.070 |
Why?
|
Infant | 6 | 2023 | 36461 | 0.070 |
Why?
|
Cell Proliferation | 6 | 2018 | 10445 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2881 | 0.070 |
Why?
|
Respiratory System | 1 | 2011 | 562 | 0.070 |
Why?
|
RNA, Neoplasm | 2 | 2014 | 747 | 0.070 |
Why?
|
Neoplasm Staging | 7 | 2023 | 11218 | 0.070 |
Why?
|
Cell Count | 3 | 2018 | 1826 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9346 | 0.070 |
Why?
|
Immobilization | 1 | 2008 | 227 | 0.070 |
Why?
|
Inclusion Bodies | 1 | 2008 | 277 | 0.070 |
Why?
|
Lymphangiosarcoma | 1 | 2006 | 14 | 0.070 |
Why?
|
Thyroid Diseases | 1 | 2010 | 385 | 0.070 |
Why?
|
Antigens, CD34 | 2 | 1999 | 656 | 0.070 |
Why?
|
Amiodarone | 1 | 2008 | 216 | 0.070 |
Why?
|
Chromosome Aberrations | 2 | 2011 | 1776 | 0.070 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2013 | 616 | 0.070 |
Why?
|
Neoplasm Metastasis | 5 | 2018 | 4891 | 0.070 |
Why?
|
Fibroblasts | 3 | 2011 | 4166 | 0.070 |
Why?
|
Brachytherapy | 1 | 2014 | 1220 | 0.070 |
Why?
|
Doxorubicin | 5 | 2014 | 2229 | 0.070 |
Why?
|
Hamartoma | 1 | 2009 | 235 | 0.070 |
Why?
|
Tendons | 1 | 2011 | 556 | 0.070 |
Why?
|
Eosinophilia | 1 | 2011 | 554 | 0.070 |
Why?
|
Animals | 24 | 2024 | 168930 | 0.060 |
Why?
|
Muscles | 2 | 2009 | 1576 | 0.060 |
Why?
|
Survival Analysis | 5 | 2018 | 10100 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 254 | 0.060 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1208 | 0.060 |
Why?
|
Low Back Pain | 1 | 2014 | 986 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2018 | 2012 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4049 | 0.060 |
Why?
|
STAT3 Transcription Factor | 1 | 2009 | 872 | 0.060 |
Why?
|
Chondrocytes | 2 | 2001 | 799 | 0.060 |
Why?
|
Pyrimidines | 2 | 2014 | 3043 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2456 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2142 | 0.060 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2009 | 734 | 0.060 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2008 | 772 | 0.060 |
Why?
|
Edema | 1 | 2008 | 764 | 0.060 |
Why?
|
Epithelium | 2 | 2001 | 1606 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2024 | 11872 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18075 | 0.060 |
Why?
|
Histiocytoma, Benign Fibrous | 2 | 2001 | 64 | 0.060 |
Why?
|
Hysterectomy | 2 | 2020 | 863 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2534 | 0.060 |
Why?
|
Rabbits | 3 | 2018 | 4752 | 0.060 |
Why?
|
Lung Neoplasms | 6 | 2021 | 13485 | 0.060 |
Why?
|
Simplexvirus | 1 | 2007 | 805 | 0.060 |
Why?
|
WT1 Proteins | 1 | 2024 | 183 | 0.050 |
Why?
|
Gout | 1 | 2011 | 622 | 0.050 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2010 | 794 | 0.050 |
Why?
|
Carcinoma, Islet Cell | 1 | 2003 | 21 | 0.050 |
Why?
|
Hindlimb | 2 | 2003 | 513 | 0.050 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2003 | 19 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 1998 | 0.050 |
Why?
|
Time Factors | 7 | 2016 | 40149 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2024 | 3607 | 0.050 |
Why?
|
Cell Division | 4 | 2012 | 4474 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1121 | 0.050 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2022 | 41 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5753 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4924 | 0.050 |
Why?
|
Mediastinum | 1 | 2023 | 272 | 0.050 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2022 | 202 | 0.050 |
Why?
|
Tumor Cells, Cultured | 5 | 2014 | 6104 | 0.050 |
Why?
|
Chromatin | 2 | 2024 | 2977 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3359 | 0.050 |
Why?
|
Oncolytic Virotherapy | 1 | 2007 | 520 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2012 | 3552 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1276 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3319 | 0.050 |
Why?
|
Omentum | 1 | 2002 | 168 | 0.050 |
Why?
|
Isochromosomes | 1 | 2000 | 16 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1834 | 0.050 |
Why?
|
Cisplatin | 3 | 2014 | 1655 | 0.050 |
Why?
|
beta 2-Microglobulin | 1 | 2021 | 330 | 0.040 |
Why?
|
Collagen Type I | 1 | 2024 | 616 | 0.040 |
Why?
|
Skull Base | 1 | 2023 | 294 | 0.040 |
Why?
|
Tissue Transplantation | 1 | 2001 | 128 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3531 | 0.040 |
Why?
|
Sirolimus | 3 | 2013 | 1540 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2001 | 2251 | 0.040 |
Why?
|
Curettage | 1 | 2020 | 74 | 0.040 |
Why?
|
Intercellular Junctions | 1 | 2001 | 198 | 0.040 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2002 | 418 | 0.040 |
Why?
|
Cytogenetic Analysis | 2 | 2011 | 270 | 0.040 |
Why?
|
Mice | 11 | 2024 | 81889 | 0.040 |
Why?
|
Fasciitis | 2 | 2000 | 66 | 0.040 |
Why?
|
Skin Transplantation | 2 | 2003 | 1097 | 0.040 |
Why?
|
Metaplasia | 1 | 2001 | 326 | 0.040 |
Why?
|
Ulna | 1 | 2001 | 134 | 0.040 |
Why?
|
Proteins | 2 | 2012 | 6002 | 0.040 |
Why?
|
Tissue Array Analysis | 2 | 2013 | 545 | 0.040 |
Why?
|
Hyalin | 1 | 1999 | 35 | 0.040 |
Why?
|
Chimera | 1 | 2001 | 455 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2014 | 904 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16044 | 0.040 |
Why?
|
Genes, p16 | 1 | 1999 | 157 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2001 | 167 | 0.040 |
Why?
|
Analysis of Variance | 4 | 2012 | 6214 | 0.040 |
Why?
|
Piperazines | 2 | 2024 | 2547 | 0.040 |
Why?
|
Mandible | 1 | 2004 | 747 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2023 | 637 | 0.040 |
Why?
|
Transplantation Immunology | 1 | 2001 | 540 | 0.040 |
Why?
|
Musculoskeletal System | 1 | 2001 | 187 | 0.040 |
Why?
|
Syndrome | 3 | 2015 | 3271 | 0.040 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 1998 | 122 | 0.040 |
Why?
|
Recurrence | 3 | 2022 | 8507 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2014 | 2060 | 0.040 |
Why?
|
Animals, Genetically Modified | 2 | 2013 | 1562 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 321 | 0.040 |
Why?
|
Lung Diseases | 1 | 2008 | 1941 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4340 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2004 | 832 | 0.040 |
Why?
|
Models, Animal | 2 | 2003 | 2121 | 0.040 |
Why?
|
Protons | 1 | 2023 | 1097 | 0.040 |
Why?
|
Endometrium | 1 | 2001 | 406 | 0.040 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 1997 | 21 | 0.040 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 157 | 0.040 |
Why?
|
Wilms Tumor | 1 | 2000 | 378 | 0.040 |
Why?
|
Random Allocation | 2 | 2014 | 2394 | 0.040 |
Why?
|
Buttocks | 1 | 1997 | 111 | 0.040 |
Why?
|
Cohort Studies | 4 | 2014 | 41710 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6066 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2010 | 718 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7475 | 0.030 |
Why?
|
Tomography | 1 | 1999 | 443 | 0.030 |
Why?
|
Organic Chemicals | 1 | 2018 | 211 | 0.030 |
Why?
|
Radiotherapy | 2 | 2008 | 1497 | 0.030 |
Why?
|
Vacuoles | 2 | 2012 | 224 | 0.030 |
Why?
|
Mitochondria | 1 | 2010 | 3677 | 0.030 |
Why?
|
DNA | 2 | 2022 | 7208 | 0.030 |
Why?
|
Abdominal Muscles | 1 | 1997 | 172 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2000 | 931 | 0.030 |
Why?
|
DNA Methylation | 2 | 2022 | 4427 | 0.030 |
Why?
|
Amyloid | 1 | 2021 | 849 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 803 | 0.030 |
Why?
|
PPAR delta | 1 | 2016 | 40 | 0.030 |
Why?
|
Endothelial Growth Factors | 1 | 1998 | 671 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 1998 | 663 | 0.030 |
Why?
|
Ovariectomy | 1 | 1998 | 612 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1751 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12534 | 0.030 |
Why?
|
Molecular Weight | 1 | 2018 | 2168 | 0.030 |
Why?
|
Germany | 1 | 2018 | 882 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.030 |
Why?
|
Hand | 1 | 2021 | 909 | 0.030 |
Why?
|
Genes, APC | 1 | 2016 | 144 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 924 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 2010 | 2470 | 0.030 |
Why?
|
Pleural Neoplasms | 1 | 2000 | 584 | 0.030 |
Why?
|
Swine, Miniature | 3 | 2002 | 972 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.030 |
Why?
|
Karyotyping | 2 | 2011 | 1176 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2015 | 156 | 0.030 |
Why?
|
Hearing Loss, Conductive | 1 | 2015 | 159 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1998 | 661 | 0.030 |
Why?
|
Pain Measurement | 2 | 2016 | 3576 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1998 | 562 | 0.030 |
Why?
|
Multiprotein Complexes | 2 | 2012 | 1110 | 0.030 |
Why?
|
Binding Sites | 1 | 2023 | 6012 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2730 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1103 | 0.030 |
Why?
|
Peripheral Nerves | 1 | 1998 | 490 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1775 | 0.030 |
Why?
|
Base Sequence | 2 | 2014 | 12415 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2392 | 0.030 |
Why?
|
Paired Box Transcription Factors | 1 | 2014 | 205 | 0.030 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 497 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2013 | 121 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2855 | 0.030 |
Why?
|
Lymphocytes | 1 | 2001 | 2605 | 0.030 |
Why?
|
Transplantation, Homologous | 4 | 2003 | 4860 | 0.030 |
Why?
|
Ploidies | 1 | 1993 | 287 | 0.030 |
Why?
|
Mesna | 1 | 2012 | 62 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1999 | 790 | 0.030 |
Why?
|
Gamma Rays | 1 | 2014 | 324 | 0.030 |
Why?
|
Cardiac Myosins | 1 | 2013 | 128 | 0.030 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
Cyclic ADP-Ribose | 1 | 2012 | 17 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9244 | 0.030 |
Why?
|
Incidence | 4 | 2015 | 21525 | 0.030 |
Why?
|
Neurofibrillary Tangles | 1 | 1995 | 457 | 0.030 |
Why?
|
S Phase | 1 | 1993 | 424 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2014 | 939 | 0.020 |
Why?
|
Ifosfamide | 1 | 2012 | 233 | 0.020 |
Why?
|
Reference Values | 1 | 1999 | 4913 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1998 | 1494 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2021 | 1790 | 0.020 |
Why?
|
Flow Cytometry | 3 | 2002 | 5890 | 0.020 |
Why?
|
Osteoclasts | 1 | 2016 | 713 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2001 | 2448 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2014 | 456 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3692 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22352 | 0.020 |
Why?
|
Cell Lineage | 1 | 2021 | 2572 | 0.020 |
Why?
|
Cartilage, Articular | 1 | 1999 | 1104 | 0.020 |
Why?
|
Abdominal Pain | 1 | 1998 | 1069 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8891 | 0.020 |
Why?
|
Hot Temperature | 1 | 2018 | 1442 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 1996 | 1159 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5754 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2274 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3439 | 0.020 |
Why?
|
Iceland | 1 | 1991 | 183 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 326 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2018 | 1275 | 0.020 |
Why?
|
Obesity | 2 | 2016 | 13090 | 0.020 |
Why?
|
Hemosiderosis | 1 | 2011 | 66 | 0.020 |
Why?
|
Cytodiagnosis | 1 | 2015 | 450 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 525 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2340 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3581 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2012 | 277 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 472 | 0.020 |
Why?
|
Genes, p53 | 1 | 2013 | 711 | 0.020 |
Why?
|
Lymphoma | 1 | 1999 | 1900 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 871 | 0.020 |
Why?
|
Eye Proteins | 1 | 2014 | 628 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1838 | 0.020 |
Why?
|
Leukemia | 1 | 2018 | 1521 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3824 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3425 | 0.020 |
Why?
|
Dioxoles | 1 | 2010 | 96 | 0.020 |
Why?
|
Tetrahydroisoquinolines | 1 | 2010 | 81 | 0.020 |
Why?
|
Cell Size | 1 | 2012 | 625 | 0.020 |
Why?
|
Particle Size | 1 | 2014 | 1634 | 0.020 |
Why?
|
Decision Making | 1 | 2004 | 3951 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4276 | 0.020 |
Why?
|
Drug Synergism | 1 | 2014 | 1756 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2012 | 303 | 0.020 |
Why?
|
Xanthenes | 1 | 2009 | 71 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7585 | 0.020 |
Why?
|
Dacarbazine | 1 | 2012 | 552 | 0.020 |
Why?
|
Organoids | 1 | 2016 | 740 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 859 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 902 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2628 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2009 | 9547 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2019 | 14471 | 0.020 |
Why?
|
Lacrimal Apparatus | 1 | 2011 | 224 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2011 | 310 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2010 | 511 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 1966 | 0.020 |
Why?
|
Polyradiculoneuropathy | 1 | 2008 | 65 | 0.020 |
Why?
|
Lung Abscess | 1 | 2008 | 39 | 0.020 |
Why?
|
Oral Surgical Procedures | 1 | 2010 | 172 | 0.020 |
Why?
|
Blotting, Western | 2 | 2010 | 5022 | 0.020 |
Why?
|
Pain | 1 | 2004 | 5098 | 0.020 |
Why?
|
Age of Onset | 1 | 2016 | 3342 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 183 | 0.020 |
Why?
|
Osteotomy | 1 | 2014 | 837 | 0.020 |
Why?
|
Cadherins | 1 | 2013 | 902 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.020 |
Why?
|
Schwann Cells | 1 | 2009 | 195 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2614 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 577 | 0.020 |
Why?
|
Osteoarthritis, Knee | 1 | 1999 | 1251 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 938 | 0.020 |
Why?
|
Coccyx | 1 | 2007 | 13 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1055 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1480 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2014 | 5306 | 0.020 |
Why?
|
Swine | 3 | 2003 | 5987 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2010 | 661 | 0.020 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2007 | 84 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4652 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1999 | 2184 | 0.020 |
Why?
|
Relative Biological Effectiveness | 1 | 2008 | 313 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1375 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 684 | 0.020 |
Why?
|
Keratin-19 | 1 | 2006 | 33 | 0.020 |
Why?
|
Keratin-7 | 1 | 2006 | 55 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2007 | 381 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1621 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2012 | 912 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2931 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 30237 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2008 | 476 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2846 | 0.020 |
Why?
|
Microvessels | 1 | 2010 | 586 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18397 | 0.020 |
Why?
|
Chylothorax | 1 | 2006 | 83 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2010 | 1867 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2010 | 712 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 1994 | 2053 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2003 | 5444 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20144 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5923 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3796 | 0.010 |
Why?
|
Genetic Markers | 1 | 2011 | 2603 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1006 | 0.010 |
Why?
|
Skin Neoplasms | 3 | 2010 | 5861 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11094 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 8066 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2014 | 12791 | 0.010 |
Why?
|
Longevity | 1 | 2012 | 1083 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22350 | 0.010 |
Why?
|
Vasculitis | 1 | 2008 | 528 | 0.010 |
Why?
|
Lower Extremity | 1 | 2012 | 1217 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1171 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2011 | 2120 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2659 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1520 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1999 | 3788 | 0.010 |
Why?
|
Plasminogen | 1 | 2003 | 144 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1646 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1994 | 2654 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2823 | 0.010 |
Why?
|
United States | 3 | 2016 | 72951 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9320 | 0.010 |
Why?
|
Prospective Studies | 3 | 2014 | 54871 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14652 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17608 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 4032 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 1995 | 3887 | 0.010 |
Why?
|
Mitotic Index | 1 | 2001 | 160 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9357 | 0.010 |
Why?
|
Graft Survival | 2 | 2002 | 3904 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2253 | 0.010 |
Why?
|
Abdominal Neoplasms | 1 | 2002 | 286 | 0.010 |
Why?
|
Spinal Cord | 1 | 2008 | 1811 | 0.010 |
Why?
|
Neurofibromatosis 2 | 1 | 2004 | 387 | 0.010 |
Why?
|
Software | 1 | 2014 | 4466 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24295 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4443 | 0.010 |
Why?
|
Histocompatibility | 1 | 2001 | 327 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6550 | 0.010 |
Why?
|
Interferometry | 1 | 1999 | 101 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10619 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2009 | 18984 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1999 | 26389 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4252 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2028 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2801 | 0.010 |
Why?
|
Cyclosporine | 1 | 2001 | 778 | 0.010 |
Why?
|
Infrared Rays | 1 | 1999 | 246 | 0.010 |
Why?
|
Endothelium | 1 | 2001 | 768 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 880 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4142 | 0.010 |
Why?
|
Microcirculation | 1 | 2003 | 1282 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2007 | 21162 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9513 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2704 | 0.010 |
Why?
|
Coloring Agents | 1 | 2000 | 565 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1998 | 456 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2010 | 15831 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5690 | 0.010 |
Why?
|
Neurofibromin 2 | 1 | 1998 | 269 | 0.010 |
Why?
|
Pleural Effusion | 1 | 2000 | 344 | 0.010 |
Why?
|
Skin | 2 | 2003 | 4499 | 0.010 |
Why?
|
Osteonecrosis | 1 | 1999 | 230 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1998 | 748 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 1617 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 2275 | 0.010 |
Why?
|
Mice, Nude | 1 | 2003 | 3616 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13640 | 0.010 |
Why?
|
Cause of Death | 1 | 2007 | 3716 | 0.010 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 1998 | 496 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 1998 | 839 | 0.010 |
Why?
|
Cytoplasm | 1 | 2000 | 1505 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 1998 | 335 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26310 | 0.010 |
Why?
|
Tooth Diseases | 1 | 1995 | 73 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1998 | 1525 | 0.010 |
Why?
|
Failure to Thrive | 1 | 1995 | 139 | 0.010 |
Why?
|
Nerve Fibers | 1 | 1998 | 706 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6507 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1994 | 11513 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 1998 | 2062 | 0.010 |
Why?
|
Hypercalcemia | 1 | 1995 | 425 | 0.010 |
Why?
|
Palliative Care | 1 | 2007 | 3640 | 0.010 |
Why?
|
Coronary Thrombosis | 1 | 1994 | 440 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2012 | 9101 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4424 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1999 | 1390 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1994 | 436 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 1999 | 1279 | 0.010 |
Why?
|
Musculoskeletal Diseases | 1 | 1995 | 598 | 0.000 |
Why?
|
Catheterization | 1 | 1994 | 1429 | 0.000 |
Why?
|
Face | 1 | 1995 | 1029 | 0.000 |
Why?
|
Tissue Plasminogen Activator | 1 | 1994 | 1164 | 0.000 |
Why?
|
Epithelial Cells | 1 | 2000 | 3691 | 0.000 |
Why?
|
Acute Disease | 1 | 1999 | 7241 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4215 | 0.000 |
Why?
|
Brain | 1 | 1995 | 27159 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1998 | 3511 | 0.000 |
Why?
|
Wound Healing | 1 | 1998 | 2800 | 0.000 |
Why?
|
Cell Line | 1 | 2001 | 15563 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 2002 | 4353 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1995 | 2101 | 0.000 |
Why?
|
Dementia | 1 | 1995 | 2741 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1995 | 15657 | 0.000 |
Why?
|